Skip to content

Impact of traditional ayurvedic preparation vs yoga vs placebo on Iron Deficiency Anemia.

Study to evaluate the efficacy of Ayurvedic Intervention with Yoga and Placebo as a treatment regime for Iron Deficiency Anemia: an open label, three arm, randomised control trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038224
Enrollment
123
Registered
2021-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50- Iron deficiency anemia

Interventions

None listed

Sponsors

Patanjali Research Institute governed by Patanjali Research Foundation Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult male and non-pregnant female population having mild or moderate Iron Deficiency anemia (IDA) caused by different aetiology such as abnormal uterine bleeding and other conditions leading to significant blood loss prior to trial enrolment. 2. Hemoglobin ranges Non pregnant women mild: 110 to 119 g per l, moderate: 80 to 109 g per l. Men, 15 years and above mild: 110 to 129 g per l, moderate: 80 to 109g per l. 3. Transferrin saturation less than 20% 4. S-ferritin less than 30 µg per l. 5. Willingness to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Anemia predominantly caused by factors other than Iron Deficiency Anemia e.g. anemia with untreated vitamin B12 or folate deficiency, sickle cell anemia, thalassemia minor. 2. Iron overload or disturbances in utilization of iron (e.g. haemochromatosis and haemosiderosis). 3. Pregnant or lactating women. 4. Known hypersensitivity to any excipients in the investigational drug products. 5. Erythropoietin treatment within 8 weeks prior to the screening visit. 6. Patients planning surgery within the trial phase or received a blood transfusion a week prior to the screening visit. 7. Any other medical condition that, in the opinion of investigator, make the patient incompetent to participate in the trial or place the patient at potential risk, e.g. any chronic comorbidity.

Design outcomes

Primary

MeasureTime frame
Change in laboratory parameters compared to baseline after 3 months of Ayurvedic intervention. Change in laboratory parameter compared to baseline after 3 months of yogic practices. Timepoint: Baseline, Day 90

Secondary

MeasureTime frame
Changes in sleep quality, quality of life, anxiety levels, fatigue, mood states and pain. Treatment satisfaction and adherence. Timepoint: Baseline, Day 45, Day 90

Countries

India

Contacts

Public ContactRitu Tyagi

Patanjali Yog Gram

clinical.investigator@prft.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026